Cargando…

The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration

PURPOSE: It is well accepted that conditions that cause central vision loss (CVL) have a negative impact on functional ability and quality of life (QoL), but the impact of diseases that cause peripheral vision loss (PVL) is less well understood. Focusing on glaucoma and age-related macular degenerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Keith, Law, Simon K, Walt, John, Buchholz, Patricia, Hansen, Jan
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724034/
https://www.ncbi.nlm.nih.gov/pubmed/19684867
_version_ 1782170386695192576
author Evans, Keith
Law, Simon K
Walt, John
Buchholz, Patricia
Hansen, Jan
author_facet Evans, Keith
Law, Simon K
Walt, John
Buchholz, Patricia
Hansen, Jan
author_sort Evans, Keith
collection PubMed
description PURPOSE: It is well accepted that conditions that cause central vision loss (CVL) have a negative impact on functional ability and quality of life (QoL), but the impact of diseases that cause peripheral vision loss (PVL) is less well understood. Focusing on glaucoma and age-related macular degeneration (ARMD), the effects of CVL and PVL on QoL were compared. METHODS: A systematic literature review of publications reporting QoL in patients with CVL or PVL identified 87 publications using four generic (Short-Form Health Survey-36 and -12, EuroQoL EQ-5D and Sickness Impact Profile) and five vision-specific (National Eye Institute Visual Function Questionnaire-51, -39, and -25, Impact of Vision Impairment and Visual Function-14) QoL instruments; 33 and 15 publications reported QoL in ARMD and glaucoma, respectively. RESULTS: QoL was impaired to a similar extent by diseases associated with PVL and CVL, but different domains were affected. In contrast to ARMD, mental aspects appeared to be affected more than physical aspects in patients with glaucoma. CONCLUSIONS: The differential impact upon QoL might be a function of the pathology of the diseases, for example potential for blindness and better ability to perform physical tasks due to retention of central vision may explain these observations in glaucoma.
format Text
id pubmed-2724034
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27240342009-08-14 The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration Evans, Keith Law, Simon K Walt, John Buchholz, Patricia Hansen, Jan Clin Ophthalmol Review PURPOSE: It is well accepted that conditions that cause central vision loss (CVL) have a negative impact on functional ability and quality of life (QoL), but the impact of diseases that cause peripheral vision loss (PVL) is less well understood. Focusing on glaucoma and age-related macular degeneration (ARMD), the effects of CVL and PVL on QoL were compared. METHODS: A systematic literature review of publications reporting QoL in patients with CVL or PVL identified 87 publications using four generic (Short-Form Health Survey-36 and -12, EuroQoL EQ-5D and Sickness Impact Profile) and five vision-specific (National Eye Institute Visual Function Questionnaire-51, -39, and -25, Impact of Vision Impairment and Visual Function-14) QoL instruments; 33 and 15 publications reported QoL in ARMD and glaucoma, respectively. RESULTS: QoL was impaired to a similar extent by diseases associated with PVL and CVL, but different domains were affected. In contrast to ARMD, mental aspects appeared to be affected more than physical aspects in patients with glaucoma. CONCLUSIONS: The differential impact upon QoL might be a function of the pathology of the diseases, for example potential for blindness and better ability to perform physical tasks due to retention of central vision may explain these observations in glaucoma. Dove Medical Press 2009 2009-08-03 /pmc/articles/PMC2724034/ /pubmed/19684867 Text en © 2009 Evans et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Evans, Keith
Law, Simon K
Walt, John
Buchholz, Patricia
Hansen, Jan
The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_full The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_fullStr The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_full_unstemmed The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_short The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_sort quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724034/
https://www.ncbi.nlm.nih.gov/pubmed/19684867
work_keys_str_mv AT evanskeith thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT lawsimonk thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT waltjohn thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT buchholzpatricia thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT hansenjan thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT evanskeith qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT lawsimonk qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT waltjohn qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT buchholzpatricia qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
AT hansenjan qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration